Role of microRNA-183 based theranostics through targeting TPM1 in bladder cancer

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Mamdouh S.; Aboushousha T.; Hemida E.; El-Araby R.E.; Elesaily K.; Hammad G.; Magdy M.

Journal: Discover Oncology

Publisher: Springer Science and Business Media B.V.

Publication Date: 13 November 2025

Volume / Issue: Volume 16 / Issue 1

Article No.: 2100

ISSN: 27306011

DOI: 10.1007/s12672-025-03829-w

Scopus: View on Scopus

Document Type: Article

Access: All Open Access; Gold Open Access; Green Open Access


Authors and Affiliations

Mamdouh S., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, Egypt; Aboushousha T., Pathology Department, Theodor Bilharz Research Institute, Giza, Egypt; Hemida E., Biochemistry Department, Obstetrics and Gynecology Hospital, Faculty of Science, Ain Shams University, Cairo, Egypt; El-Araby R.E., Department of Basic and Clinical Translation Sciences, Tufts University School of Dental Medicine, Boston, 02111, MA, United States, Central Lab, Theodor Bilharz Research Institute, Giza, Egypt; Elesaily K., Urology Department, Theodor Bilharz Research Institute, Giza, Egypt; Hammad G., Faculty of Biotechnology, October University for Modern Sciences and Arts, Giza, Egypt; Magdy M., Pathology Department, Theodor Bilharz Research Institute, Giza, Egypt


Abstract

Background: MicroRNA-183 (miR-183-5p), a noncoding RNA, is upregulated in bladder carcinoma (BC). Although it has been implicated in oncogenesis, its precise regulatory effects and biological functions remain unclear. Tropomyosin-1 (TPM1) was shown to be downregulated in solid tumors and was previously identified as a novel tumor suppressor gene. Objectives: Our study focuses on the prognostic, diagnostic, and therapeutic potential of miR-183-5p in bladder carcinoma and assess TPM1 gene targets and their modulatory functions. Methods: Urine cytology, cystectomy and transurethral resection (TUR) biopsies from 148 BC patients were collected. TPM1 protein and miR-183-5p expressions were assessed through immunohistochemistry (IHC) and real-time PCR respectively. In vitro assay investigated the effect of miR-183-5p on TPM1mRNA in bladder carcinoma cell lines, then confirmed by comparing miR-183-5p mimics in non-cancerous and urothelial carcinoma cell lines. Concomitant TPM1 gene expression was examined, and the theranostic miR-183-5p potential was evaluated. Results: Upregulation of miR-183-5p expression in BC tissue biopsies and urine cytologies was noted, contrasting the downregulation of TPM1 protein expression in the high-grade, high-stage, lymph node metastatic BC tissues (in comparison to non-cancerous, low-grade, low-stage non-lymph node metastasizing BCs). Moreover, the miR-183-5p oncogenic influence was responsive in targeting TPM1 gene at 3′UTR region, and miR‑183‑5p.1 restricted TPM1 expression in T24 cells. Conclusion: This study provides the first illustration of the miR-183-5p–TPM1 axis in bladder carcinoma, supporting the theranostic role of miR-183-5p as an onco-miR in BC progression, diagnosis, and prognostication. © The Author(s) 2025.


Keywords

Biopsy; Bladder carcinomas; MicroRNA; miR-183-5p; Theranostic; TPM1; Urine cytology; alpha tropomyosin; microRNA 183; miR 183 5p; unclassified drug; Article; biotechnology; bladder cancer; bladder carcinoma; cancer staging; carcinoma cell line; controlled study; cystectomy; diagnostic test accuracy study; electronic spreadsheet; female; gene; genetic transfection; human; human cell; human tissue; immunohistochemistry; major clinical study; male; protein expression; real time polymerase chain reaction; receiver operating characteristic; SV-HUC-1 cell line; T24 cell line; theranostics; TPM1 gene; transurethral resection; transurethral resection of bladder tumor; transurethral resection of the bladder; tumor suppressor gene; urothelial carcinoma cell line


Citation Information

Scopus Citations: 0


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Multifunctional polycaprolactone-based composite fibers with icariin and glutathione for effective repair of critical-sized bone defects

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region